The newer herpesviruses are being increasingly recognized as significant op
portunistic pathogens in organ transplant recipients. Published data suppor
t the role of human herpesvirus-6 as a potential cause of encephalitis and
bone marrow suppression in transplant setting. An association of human herp
esvirus-6 with fungal infections and cytomegalovirus infection has also bee
n documented. Human herpesvirus-7 also appears to be an immunomodulatory ag
ent and may facilitate the pathogenicity of cytomegalovirus. Unlike human h
erpesviruses -6 and -7, human herepsvirus-8 is not ubiquitous; its seroprev
alence exhibits wide geographic variation. Human herpesvirus-8 has been cau
sally associated with post-transplant Kaposi's sarcoma. The complete spectr
um of pathogenicity and ultimately the effective prophylaxis and management
of these viruses has yet to be fully elucidated.